Connect with us

News

These European Countries are Pushing to Legalize Cannabis: The EU’s Stance and Challenges

These European Countries are Pushing to Legalize Cannabis The EU's Stance and Challenges

Introduction

In recent years, cannabis legalization has gained significant traction globally. While some countries have taken bold steps toward legalization, others remain hesitant to embrace the change.

Several European countries are pushing for the legalization of cannabis, despite the European Union’s reservations.

This article explores the current status of cannabis legalization in Europe, the reasons behind the push for legalization, the challenges faced, and the EU’s stance on the matter.

Current Status of Cannabis Legalization in Europe

Cannabis laws vary widely across European countries. Some nations have adopted more progressive approaches, while others maintain strict prohibitions.

For instance, countries like the Netherlands, Spain, Portugal, and Luxembourg have implemented frameworks that decriminalize or regulate marijuana to some extent.

On the other hand, the EU has not endorsed or supported the legalization of cannabis at the supranational level, leaving individual member states to determine their policies.

Reasons for Pushing Cannabis Legalization

The push for marijuana legalization in European countries stems from various factors, including economic benefits, social and public health considerations, and medical use and patient access.

Economic Benefits

Legalizing cannabis can have a significant impact on a country’s economy. It opens up opportunities for tax revenue, job creation, and tourism. By regulating and taxing the cannabis market, countries can generate substantial income that can be reinvested in public services, infrastructure, or education.

Social and Public Health Considerations

Proponents of marijuana legalization argue that regulating the market can help mitigate the negative consequences of the illicit drug trade.

It allows for quality control, product safety standards, and age restrictions, reducing the risks associated with consumption. Moreover, it frees up law enforcement resources, enabling authorities to focus on more pressing matters.

Medical Use and Patient Access

The medicinal properties of marijuana have been widely recognized, and patients suffering from various conditions often seek its therapeutic benefits.

Legalization can provide a framework for medical cannabis programs, ensuring safe and regulated access for needy patients. It also fosters research and development, leading to advancements in cannabis-based medicines.

Challenges and Opposition to Cannabis Legalization

Despite the growing support for cannabis legalization, several challenges and opposition persist.

International Drug Control Treaties

One of the primary obstacles to marijuana legalization is the existing international drug control treaties. Many European countries sign these treaties, which impose obligations to restrict marijuana use and trade.

However, some argue that these treaties must be revisited to adapt to evolving societal attitudes and scientific understanding.

Concerns about Public Health and Safety

Opponents of cannabis legalization express concerns about potential public health and safety risks associated with increased availability and use of the drug.

They argue that cannabis use can lead to negative health effects, particularly among vulnerable populations such as adolescents. They also raise concerns about impaired driving and the potential for addiction or dependency.

Lack of Consensus within the European Union

One of the reasons the European Union has not embraced marijuana legalization is the lack of consensus among member states. Each country has its unique perspective and approach to drug policy, making it challenging to reach a unified stance.

Some countries favor more lenient regulations, while others maintain a strict prohibitionist approach. This lack of consensus hinders the EU from formulating a coherent policy on marijuana legalization.

The Role of Cannabis Tourism

Cannabis tourism has emerged as a significant factor influencing the push for legalization in some European countries.

Countries like the Netherlands and Spain, known for their more relaxed marijuana policies, have seen an influx of tourists seeking to experience marijuana culture.

Legalization can help regulate this industry, ensuring that it operates safely and responsibly while capitalizing on the economic benefits of marijuana tourism and boosting local economies.

The Potential Impact on Neighboring Countries

Countries considering marijuana legalization must also consider the potential impact on neighboring nations.

Concerns include cross-border drug trafficking, disparities in drug policies leading to legal inconsistencies, and the strain on law enforcement agencies tasked with monitoring the borders.

Collaboration and coordination among neighboring countries are crucial to address these potential challenges.

Case Studies of Countries Pushing for Cannabis Legalization

Several European countries have taken notable steps toward marijuana legalization, providing valuable case studies.

The Netherlands

The Netherlands is often cited as a pioneer in cannabis policy. While cannabis remains technically illegal, the country has implemented a tolerance system, allowing the sale and consumption of cannabis in designated coffee shops. This pragmatic approach has contributed to the Netherlands’ reputation as a cannabis-friendly destination.

Spain

Spain has adopted a decentralized approach to cannabis regulation, granting autonomy to regional governments to develop their policies.

Consequently, various regions in Spain have established cannabis social clubs where members can cultivate and consume marijuana in a private, non-commercial setting.

Portugal

Portugal stands out for its progressive drug policy, decriminalizing drug possession for personal use. While marijuana remains technically illegal, its possession and use are considered an administrative offense rather than a criminal one. This approach has redirected resources toward public health and harm reduction strategies.

Luxembourg

Luxembourg made headlines in 2018 when it announced plans to become the first European country to fully legalize cannabis.

The government aims to establish a regulated market, allowing the production, distribution, and sale of cannabis for recreational use.

The legislation is being developed, and other countries will closely monitor Luxembourg’s approach.

Lessons from Countries with Legalized Cannabis

Countries with legalized cannabis offer valuable lessons for others considering similar policies.

These lessons include the importance of comprehensive regulatory frameworks, public education and awareness campaigns, robust taxation systems, and continuous evaluation and adaptation based on emerging evidence and data.

The EU’s Stance on Cannabis Legalization

The European Union does not have a unified stance on marijuana legalization. The decision to legalize cannabis remains within the jurisdiction of individual member states.

The EU primarily supports scientific research, fosters cooperation, and promotes information exchange among member states.

Conclusion

The push for cannabis legalization in Europe continues to gain momentum, with several countries advocating for change. The economic benefits, social considerations, and medical use drive this movement.

However, challenges such as international drug control treaties, public health concerns, and the lack of consensus within the European Union pose significant obstacles.

By closely examining countries’ experiences that have already legalized marijuana and fostering dialogue and cooperation among member states, European countries can navigate the complexities of marijuana legalization.

FAQs

  1. Is marijuana fully legalized in any European country?

No, marijuana is not fully legalized in any European country. While some countries have adopted more lenient policies, such as decriminalization or regulation for specific purposes, full legalization remains rare.

  1. What are the economic benefits of marijuana legalization?

marijuana legalization can generate significant economic benefits, including tax revenue, job creation, and tourism opportunities. It provides an avenue for legal businesses to thrive and contributes to the overall economy.

  1. What are the concerns about marijuana legalization?

Concerns about marijuana legalization include potential negative health effects, risks to public safety, and challenges in enforcing regulations. There are also concerns about the potential for increased marijuana use among vulnerable populations.

  1. Does the European Union support marijuana legalization?

The European Union does not have a unified stance on marijuana legalization. The decision to legalize marijuana falls within the jurisdiction of individual member states, while the EU focuses on supporting research and facilitating cooperation among countries.

Related CTN News:

How to Make COVID Vaccines at Home: A Comprehensive Guide to the Development and Manufacturing Process”

News

Google’s Search Dominance Is Unwinding, But Still Accounting 48% Search Revenue

Google

Google is so closely associated with its key product that its name is a verb that signifies “search.” However, Google’s dominance in that sector is dwindling.

According to eMarketer, Google will lose control of the US search industry for the first time in decades next year.

Google will remain the dominant search player, accounting for 48% of American search advertising revenue. And, remarkably, Google is still increasing its sales in the field, despite being the dominating player in search since the early days of the George W. Bush administration. However, Amazon is growing at a quicker rate.

google

Google’s Search Dominance Is Unwinding

Amazon will hold over a quarter of US search ad dollars next year, rising to 27% by 2026, while Google will fall even more, according to eMarketer.

The Wall Street Journal was first to report on the forecast.

Lest you think you’ll have to switch to Bing or Yahoo, this isn’t the end of Google or anything really near.

Google is the fourth-most valued public firm in the world. Its market worth is $2.1 trillion, trailing just Apple, Microsoft, and the AI chip darling Nvidia. It also maintains its dominance in other industries, such as display advertisements, where it dominates alongside Facebook’s parent firm Meta, and video ads on YouTube.

To put those “other” firms in context, each is worth more than Delta Air Lines’ total market value. So, yeah, Google is not going anywhere.

Nonetheless, Google faces numerous dangers to its operations, particularly from antitrust regulators.

On Monday, a federal judge in San Francisco ruled that Google must open up its Google Play Store to competitors, dealing a significant blow to the firm in its long-running battle with Fortnite creator Epic Games. Google announced that it would appeal the verdict.

In August, a federal judge ruled that Google has an illegal monopoly on search. That verdict could lead to the dissolution of the company’s search operation. Another antitrust lawsuit filed last month accuses Google of abusing its dominance in the online advertising business.

Meanwhile, European regulators have compelled Google to follow tough new standards, which have resulted in multiple $1 billion-plus fines.

google

Pixa Bay

Google’s Search Dominance Is Unwinding

On top of that, the marketplace is becoming more difficult on its own.

TikTok, the fastest-growing social network, is expanding into the search market. And Amazon has accomplished something few other digital titans have done to date: it has established a habit.

When you want to buy anything, you usually go to Amazon, not Google. Amazon then buys adverts to push companies’ products to the top of your search results, increasing sales and earning Amazon a greater portion of the revenue. According to eMarketer, it is expected to generate $27.8 billion in search revenue in the United States next year, trailing only Google’s $62.9 billion total.

And then there’s AI, the technology that (supposedly) will change everything.

Why search in stilted language for “kendall jenner why bad bunny breakup” or “police moving violation driver rights no stop sign” when you can just ask OpenAI’s ChatGPT, “What’s going on with Kendall Jenner and Bad Bunny?” in “I need help fighting a moving violation involving a stop sign that wasn’t visible.” Google is working on exactly this technology with its Gemini product, but its success is far from guaranteed, especially with Apple collaborating with OpenAI and other businesses rapidly joining the market.

A Google spokeswoman referred to a blog post from last week in which the company unveiled ads in its AI overviews (the AI-generated text that appears at the top of search results). It’s Google’s way of expressing its ability to profit on a changing marketplace while retaining its business, even as its consumers steadily transition to ask-and-answer AI and away from search.

google

Google has long used a single catchphrase to defend itself against opponents who claim it is a monopoly abusing its power: competition is only a click away. Until recently, that seemed comically obtuse. Really? We are going to switch to Bing? Or Duck Duck Go? Give me a break.

But today, it feels more like reality.

Google is in no danger of disappearing. However, every highly dominating company faces some type of reckoning over time. GE, a Dow mainstay for more than a century, was broken up last year and is now a shell of its previous dominance. Sears declared bankruptcy in 2022 and is virtually out of business. US Steel, long the foundation of American manufacturing, is attempting to sell itself to a Japanese corporation.

Could we remember Google in the same way that we remember Yahoo or Ask Jeeves in decades? These next few years could be significant.

SOURCE | CNN

Continue Reading

News

The Supreme Court Turns Down Biden’s Government Appeal in a Texas Emergency Abortion Matter.

Supreme Court

(VOR News) – A ruling that prohibits emergency abortions that contravene the Supreme Court law in the state of Texas, which has one of the most stringent abortion restrictions in the country, has been upheld by the Supreme Court of the United States. The United States Supreme Court upheld this decision.

The justices did not provide any specifics regarding the underlying reasons for their decision to uphold an order from a lower court that declared hospitals cannot be legally obligated to administer abortions if doing so would violate the law in the state of Texas.

Institutions are not required to perform abortions, as stipulated in the decree. The common populace did not investigate any opposing viewpoints. The decision was made just weeks before a presidential election that brought abortion to the forefront of the political agenda.

This decision follows the 2022 Supreme Court ruling that ended abortion nationwide.

In response to a request from the administration of Vice President Joe Biden to overturn the lower court’s decision, the justices expressed their disapproval.

The government contends that hospitals are obligated to perform abortions in compliance with federal legislation when the health or life of an expectant patient is in an exceedingly precarious condition.

This is the case in regions where the procedure is prohibited. The difficulty hospitals in Texas and other states are experiencing in determining whether or not routine care could be in violation of stringent state laws that prohibit abortion has resulted in an increase in the number of complaints concerning pregnant women who are experiencing medical distress being turned away from emergency rooms.

The administration cited the Supreme Court’s ruling in a case that bore a striking resemblance to the one that was presented to it in Idaho at the beginning of the year. The justices took a limited decision in that case to allow the continuation of emergency abortions without interruption while a lawsuit was still being heard.

In contrast, Texas has been a vocal proponent of the injunction’s continued enforcement. Texas has argued that its circumstances are distinct from those of Idaho, as the state does have an exemption for situations that pose a significant hazard to the health of an expectant patient.

According to the state, the discrepancy is the result of this exemption. The state of Idaho had a provision that safeguarded a woman’s life when the issue was first broached; however, it did not include protection for her health.

Certified medical practitioners are not obligated to wait until a woman’s life is in imminent peril before they are legally permitted to perform an abortion, as determined by the state supreme court.

The state of Texas highlighted this to the Supreme Court.

Nevertheless, medical professionals have criticized the Texas statute as being perilously ambiguous, and a medical board has declined to provide a list of all the disorders that are eligible for an exception. Furthermore, the statute has been criticized for its hazardous ambiguity.

For an extended period, termination of pregnancies has been a standard procedure in medical treatment for individuals who have been experiencing significant issues. It is implemented in this manner to prevent catastrophic outcomes, such as sepsis, organ failure, and other severe scenarios.

Nevertheless, medical professionals and hospitals in Texas and other states with strict abortion laws have noted that it is uncertain whether or not these terminations could be in violation of abortion prohibitions that include the possibility of a prison sentence. This is the case in regions where abortion prohibitions are exceedingly restrictive.

Following the Supreme Court’s decision to overturn Roe v. Wade, which resulted in restrictions on the rights of women to have abortions in several Republican-ruled states, the Texas case was revisited in 2022.

As per the orders that were disclosed by the administration of Vice President Joe Biden, hospitals are still required to provide abortions in cases that are classified as dire emergency.

As stipulated in a piece of health care legislation, the majority of hospitals are obligated to provide medical assistance to patients who are experiencing medical distress. This is in accordance with the law.

The state of Texas maintained that hospitals should not be obligated to provide abortions throughout the litigation, as doing so would violate the state’s constitutional prohibition on abortions. In its January judgment, the 5th United States Circuit Court of Appeals concurred with the state and acknowledged that the administration had exceeded its authority.

SOURCE: AP

SEE ALSO:

Could Last-Minute Surprises Derail Kamala Harris’ Campaign? “Nostradamus” Explains the US Poll.

Scientists Awarded MicroRNA The Nobel Prize in Medicine.

US Inflation will Comfort a Fed Focused on Labor Markets.

Continue Reading

News

Supreme Court Rejects Appeal From ‘Pharma Bro’ Martin Shkreli, To repay $6.4 Million

shkreli

Washington — The Supreme Court rejected Martin Shkreli’s appeal on Monday, after he was branded “Pharma Bro” for raising the price of a lifesaving prescription.

Martin appealed a decision to repay $64.6 million in profits he and his former company earned after monopolizing the pharmaceutical market and dramatically raising its price. His lawyers claimed the money went to his company rather than him personally.

The justices did not explain their reasoning, as is customary, and there were no notable dissents.

Prosecutors, conversely, claimed that the firm had promised to pay $40 million in a settlement and that because Martin orchestrated the plan, he should be held accountable for returning profits.

shkreli

Supreme Court Rejects Appeal From ‘Pharma Bro’ Martin Shkreli

Martin was also forced to forfeit the Wu-Tang Clan’s unreleased album “Once Upon a Time in Shaolin,” which has been dubbed the world’s rarest musical album. The multiplatinum hip-hop group auctioned off a single copy of the record in 2015, stipulating that it not be used commercially.

Shkreli was convicted of lying to investors and defrauding them of millions of dollars in two unsuccessful hedge funds he managed. Shkreli was the CEO of Turing Pharmaceuticals (later Vyera), which hiked the price of Daraprim from $13.50 to $750 per pill after acquiring exclusive rights to the decades-old medicine in 2015. It cures a rare parasite condition that affects pregnant women, cancer patients, and HIV patients.

shkreli

He defended the choice as an example of capitalism in action, claiming that insurance and other programs ensured that those in need of Daraprim would eventually receive it. However, the move prompted criticism, from the medical community to Congress.

shkreli

Supreme Court Rejects Appeal From ‘Pharma Bro’ Martin Shkreli

Attorney Thomas Huff said the Supreme Court’s Monday ruling was upsetting, but the high court could still overturn a lower court judgment that allowed the $64 million penalty order even though Shkreli had not personally received the money.

“If and when the Supreme Court does so, Mr. Shkreli will have a strong argument for modifying the order accordingly,” he told reporters.

Shkreli was freed from prison in 2022 after serving most of his seven-year sentence.

SOURCE | AP

Continue Reading

Trending